Cardea Bio has been featured in the April 2021 Emerging Startups 2021: Top Life Sciences Platforms and Tools. Life Sciences Platforms and Tools is one of the most active sectors for investors, with an overall funding of USD 72.5B in 3.9K+ companies. It is also interesting to note that more than one third of the funding has been raised in the last 3 years (2018-2020).
See the complete article at Tracxn
This post was originally published at https://www.cardeabio.com/news/emerging-startups-2021-top-life-sciences-platforms. Cardea Bio was acquired by Paragraf on 2 May 2023.
